Your endocannabinoid system ain’t the sharpest tool in the shed when cannabinoids flood your CB1 receptors all at once. Turns out tolerance develops faster than you can say “tolerance break.” Further Reading...
One Does Not Simply
One does not simply explain the endocannabinoid system to a patient in under fifteen minutes. Further Reading Cannabis NewsRecreational drugs triple the risk of stroke in young people, study finds | The...
`Endocannabinoid System & PTSD: Cannabis Meta-Analysis`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments. Cannabis use does not appear to prevent or significantly undermine the effectiveness...
endocannabinoid system clinical research: Mobile Mental Health RCT
Clinical Takeaway A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use during a high-risk transitional period. Digital tools like this are...
`Endocannabinoid System & Athlete Mental Health Research`
Clinical Takeaway Retired professional athletes from high contact team sports face elevated rates of depression, anxiety, and other mental health challenges compared to the general population, with factors like repetitive head trauma,...
`Cannabinoids for Children: Clinical Evidence Reviewed`
Clinical Takeaway Current evidence on cannabinoids in pediatric patients spans 276 studies across multiple designs, capturing both plant-derived and pharmaceutical formulations used to treat medical conditions in children under 18. The research...
Endocannabinoid System Trial: Cannabis for Chronic Back Pain
Clinical Takeaway In this phase 3 randomized controlled trial, 820 adults with chronic low back pain received either VER-01, a full-spectrum cannabis extract, or placebo over a 12-week double-blind period, with extensions...
Endocannabinoid System: Cannabis for Chronic Pain Review
Clinical Takeaway Clinical trials show that cannabis-based products with higher THC content provide modest but measurable reductions in chronic pain compared to placebo. Evidence quality varies by product type, THC-to-CBD ratio, and...
Germany’s Post-CanG Import Surge Loses Steam as Q4 Growth Stalls – Business of Cannabis
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearch Why This Matters Germany’s slowdown in cannabis imports following legalization (CanG) signals that initial...
Curaleaf, Trulieve, Green Thumb Industries, Verano, Cresco Labs and Tilray Brands – Yahoo Finance
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchIndustry Why This Matters Clinicians need to understand the regulatory landscape across jurisdictions because their...